Literature DB >> 21941148

Complete resolution of sickle cell chronic pain with high dose vitamin D therapy: a case report and review of the literature.

Ifeyinwa Osunkwo1.   

Abstract

With age, individuals with sickle cell disease (SCD) experience daily chronic pain. Vitamin D deficiency (VDD) can result in chronic pain, osteoporosis, fractures, and muscle weakness. Several studies report a high prevalence of VDD in SCD; however, the clinical correlates have not been well described. We describe a case of SCD chronic pain associated with profound VDD, osteoporosis, and osteonecrosis. Treatment with high-dose vitamin D resulted in complete resolution of chronic pain symptoms and improvement in bone density. Randomized studies of vitamin D in SCD may help elucidate its role in the management of chronic pain and bone disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21941148     DOI: 10.1097/MPH.0b013e31821ed3ea

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  12 in total

Review 1.  Vitamin D supplementation for sickle cell disease.

Authors:  Htoo Htoo Kyaw Soe; Adinegara Bl Abas; Nan Nitra Than; Han Ni; Jaspal Singh; Abdul Razzak Bin Mohd Said; Ifeyinwa Osunkwo
Journal:  Cochrane Database Syst Rev       Date:  2017-01-20

Review 2.  A review on vitamin d deficiency treatment in pediatric patients.

Authors:  Ji Yeon Lee; Tsz-Yin So; Jennifer Thackray
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

3.  Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease.

Authors:  Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

4.  High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study.

Authors:  Ifeyinwa Osunkwo; Thomas R Ziegler; Jessica Alvarez; Courtney McCracken; Korin Cherry; Chinyere E Osunkwo; Solomon F Ofori-Acquah; Samit Ghosh; Adeolu Ogunbobode; Jim Rhodes; James R Eckman; Carlton Dampier; Vin Tangpricha
Journal:  Br J Haematol       Date:  2012-08-28       Impact factor: 6.998

Review 5.  Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.

Authors:  Patrick J McCullough; William P McCullough; Douglas Lehrer; Jeffrey B Travers; Steven J Repas
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

6.  Osteoarticular involvement in sickle cell disease.

Authors:  Geraldo Bezerra da Silva Junior; Elizabeth De Francesco Daher; Francisco Airton Castro da Rocha
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 7.  Prevalence of vitamin D deficiency in sickle cell disease: a systematic review.

Authors:  Vikki G Nolan; Kerri A Nottage; Elliott W Cole; Jane S Hankins; James G Gurney
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

8.  Vitamin D supplementation for sickle cell disease.

Authors:  Htoo Htoo Kyaw Soe; Adinegara Bl Abas; Nan Nitra Than; Han Ni; Jaspal Singh; Abdul Razzak Bin Mohd Said; Ifeyinwa Osunkwo
Journal:  Cochrane Database Syst Rev       Date:  2020-05-28

9.  Effect of prophylactic vitamin D on anesthetic outcome in children with sickle cell disease.

Authors:  Tarek Shams; Hamed Al Wadani; Ragaa El-Masry; Ossama Zakaria
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01

10.  Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa.

Authors:  Bamidele O Tayo; Titilola S Akingbola; Babatunde L Salako; Colin A McKenzie; Marvin Reid; Jennifer Layden; Ifeyinwa Osunkwo; Jacob Plange-Rhule; Amy Luke; Ramon Durazo-Arvizu; Richard S Cooper
Journal:  BMC Hematol       Date:  2014-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.